Related by context. Frequent words. (Click for all words.) 71 NASDAQ LGND 71 Inc Therapeutic Competitors 69 Inc. Nasdaq IMGN 69 Presents Positive 69 Files Shelf Registration Statement 69 Idera Pharmaceuticals Inc. 68 www.syntapharma.com 68 Idera Pharmaceuticals 68 EPIX Pharmaceuticals Inc. 67 ARIAD Pharmaceuticals Inc. 67 +#-#-#-# Ext [001] 67 CONTACT Investor Relations 67 www.twitter.com otcadvisors 67 Ligand Pharmaceuticals Incorporated 67 RegeneRx Biopharmaceuticals Inc. 66 Genaera Corporation 66 Inc. Nasdaq SEPR 66 Calls Purchased 66 NASDAQ ARIA 66 NASDAQ IMCL 66 NOT REVIEWED AND DOES 66 Completes Enrollment 66 Adolor Corporation 66 IMPAX Laboratories Inc. 65 Inc. Nasdaq SGEN 65 Connetics Corporation 65 RELEASES ITS QUARTERLY NUMBERS 65 iBio Inc. 65 NovaBay Pharmaceuticals Inc. 65 Regado Biosciences 65 NASDAQ CYPB 65 INVESTOR CONTACT 65 www.facebook.com/pages/OTC-ADVISORS-LLC/#veejay 65 Company Nasdaq PRGO 65 Metabasis Therapeutics Inc. 65 Sunesis Pharmaceuticals Inc. 65 ZIOPHARM Oncology Inc. 65 www.combinatorx.com 65 http:/profnet.prnewswire.com/ud public.jsp?useridShuan 65 ADVENTRX Pharmaceuticals Inc. 65 RELATIVELY GOOD PERFORMANCE DETECTED 65 SGMO 65 Cyclacel Pharmaceuticals Inc. 65 NOT ACCEPT RESPONSIBILITY FOR 64 +#-#-#-# x# [002] 64 Heilshorn & 64 Stock Downgraded 64 CONTAINS FORWARD LOOKING STATEMENTS 64 Hybridon 64 ImmuneRegen BioSciences Inc. 64 Stock Upgraded 64 https:/profnet.prnewswire.com/Subscriber/ExpertPrBANGKOK Thomson Financial 64 DVAX 64 PROFILE CO 64 Nastech Pharmaceutical Company 64 Biopure Corporation 64 Kim Esq 64 ENZN 64 Nasdaq AMLN 64 Q2 Loss Narrows 64 Joins OTCQX 64 XOMA Ltd. 64 NASDAQ SHPGY 64 Genelabs Technologies Inc. 64 NASDAQ CRXL 64 msnyder@freepress.com 64 Noonan Russo 64 Nasdaq VRTX 64 THE TREND CONTINUES LOWER 64 DURECT Corporation 64 Nasdaq ALTH 64 EpiCept Corporation 64 Bearish Pressure Building 64 Aradigm Corporation 64 NASDAQ OSIR 64 Nasdaq BDSI 64 LYON France BUSINESS WIRE 63 http:/www.ariad.com 63 Report companiesandmarkets.com adds 63 Advancing Drugs 63 HAS BEEN PREPARED BY 63 Healthnostics Inc. 63 Inc. NASDAQ HGSI 63 Contact MARK SNYDER 63 Initiates Phase 63 http:/profnet.prnewswire.com/Subscriber/ExpertProJim Argue 63 Announces Initiation 63 EVC Group 63 Harbor BioSciences 63 NovaBay Pharmaceuticals 63 www.pdl.com 63 Cerus Corporation 63 Alseres Pharmaceuticals Inc. 63 PYMX 63 Pluristem Therapeutics Inc. 63 Barrier Therapeutics Inc. 63 Vicor Technologies Inc. 63 www.tekmirapharm.com 63 BioSpecifics Technologies Corp. 63 READ THE PROXY 63 Skymark Research Initiates Independent